最新报道:180 Life Sciences Corp. (NASDAQ: ATNF) announced that it sold approximately $156 million in principal amount of its senior secured convertible notes due 2028 (the "Convertible Notes") to an institutional investor in a private placement on August 8. The company plans to use the net proceeds from the Convertible Notes to purchase additional ether (ETH). This offering further expands the company's recently announced ETH fund management strategy. The company plans to provide investors with regular updates on its ETH holdings in the near term to ensure maximum transparency.